Article
Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
Stem cell research - 1 Aug 2018
Zhang Xiao, Zhang Dan, Chen Shang-Chih, Lamey Tina, Thompson Jennifer A, McLaren Terri, De Roach John N, Chen Fred K, McLenachan Samuel
Abstract excerpt
The human iPSC line LEIi006-A was generated from dermal fibroblasts from a patient with retinitis pigmentosa using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. The iPSC cells carry compound heterozygous mutations (c.1892A > G and c.2548G > A) in the CRB1 gene. LEIi006-A expressed pluripotent stem cell markers, had a normal karyotype and could be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
